167 related articles for article (PubMed ID: 21530083)
1. Temporal IgG subclasses response in dogs following vaccination against Leishmania with Leishmune®.
Marcondes M; Ikeda FA; Vieira RF; Day MJ; Lima VM; Rossi CN; Perri SH; Biondo AW
Vet Parasitol; 2011 Sep; 181(2-4):153-9. PubMed ID: 21530083
[TBL] [Abstract][Full Text] [Related]
2. IgG subclass profile of serum antibodies to Leishmania chagasi in naturally infected and vaccinated dogs.
Oliveira TM; Mineo TW; Bason M; Day MJ; Machado RZ
Vet Parasitol; 2009 May; 162(1-2):16-22. PubMed ID: 19345019
[TBL] [Abstract][Full Text] [Related]
3. Clinical value of anti-Leishmania (Leishmania) chagasi IgG titers detected by flow cytometry to distinguish infected from vaccinated dogs.
de Andrade RA; Reis AB; Gontijo CM; Braga LB; Rocha RD; Araújo MS; Vianna LR; Martins-Filho OA
Vet Immunol Immunopathol; 2007 Mar; 116(1-2):85-97. PubMed ID: 17287029
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal analysis of serological tests officially adopted by the Brazilian Ministry of Health for the diagnosis of canine visceral leishmaniasis in dogs vaccinated with Leishmune®.
Marcondes M; de Lima VM; de Araújo Mde F; Hiramoto RM; Tolezano JE; Vieira RF; Biondo AW
Vet Parasitol; 2013 Nov; 197(3-4):649-52. PubMed ID: 23920056
[TBL] [Abstract][Full Text] [Related]
5. Comparison of two commercial vaccines against visceral leishmaniasis in dogs from endemic areas: IgG, and subclasses, parasitism, and parasite transmission by xenodiagnosis.
Fernandes CB; Junior JT; de Jesus C; Souza BM; Larangeira DF; Fraga DB; Tavares Veras PS; Barrouin-Melo SM
Vaccine; 2014 Mar; 32(11):1287-95. PubMed ID: 24406392
[TBL] [Abstract][Full Text] [Related]
6. Leishmune vaccine blocks the transmission of canine visceral leishmaniasis: absence of Leishmania parasites in blood, skin and lymph nodes of vaccinated exposed dogs.
Nogueira FS; Moreira MA; Borja-Cabrera GP; Santos FN; Menz I; Parra LE; Xu Z; Chu HJ; Palatnik-de-Sousa CB; Luvizotto MC
Vaccine; 2005 Sep; 23(40):4805-10. PubMed ID: 16011864
[TBL] [Abstract][Full Text] [Related]
7. Antileishmanial antibody profile in dogs naturally infected with Leishmania chagasi.
Almeida MA; Jesus EE; Sousa-Atta ML; Alves LC; Berne ME; Atta AM
Vet Immunol Immunopathol; 2005 Jun; 106(1-2):151-8. PubMed ID: 15911002
[TBL] [Abstract][Full Text] [Related]
8. Humoral immunological profile and parasitological statuses of Leishmune vaccinated and visceral leishmaniasis infected dogs from an endemic area.
de Amorim IF; Freitas E; Alves CF; Tafuri WL; Melo MN; Michalick MS; da Costa-Val AP
Vet Parasitol; 2010 Oct; 173(1-2):55-63. PubMed ID: 20638182
[TBL] [Abstract][Full Text] [Related]
9. Profile of anti-Leishmania antibodies related to clinical picture in canine visceral leishmaniasis.
de Freitas JC; Lopes-Neto BE; de Abreu CR; Coura-Vital W; Braga SL; Reis AB; Nunes-Pinheiro DC
Res Vet Sci; 2012 Oct; 93(2):705-9. PubMed ID: 22226072
[TBL] [Abstract][Full Text] [Related]
10. Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial.
Lemesre JL; Holzmuller P; Gonçalves RB; Bourdoiseau G; Hugnet C; Cavaleyra M; Papierok G
Vaccine; 2007 May; 25(21):4223-34. PubMed ID: 17395339
[TBL] [Abstract][Full Text] [Related]
11. The FML-vaccine (Leishmune) against canine visceral leishmaniasis: a transmission blocking vaccine.
Saraiva EM; de Figueiredo Barbosa A; Santos FN; Borja-Cabrera GP; Nico D; Souza LO; de Oliveira Mendes-Aguiar C; de Souza EP; Fampa P; Parra LE; Menz I; Dias JG; de Oliveira SM; Palatnik-de-Sousa CB
Vaccine; 2006 Mar; 24(13):2423-31. PubMed ID: 16386824
[TBL] [Abstract][Full Text] [Related]
12. T-cell-derived cytokines, nitric oxide production by peripheral blood monocytes and seric anti-Leishmania (Leishmania) chagasi IgG subclass patterns following immunization against canine visceral leishmaniasis using Leishvaccine and Leishmune.
Araújo MS; de Andrade RA; Sathler-Avelar R; Teixeira-Carvalho A; Andrade MC; Vianna LR; Mayrink W; Reis AB; Malaquias LC; Mello MN; Martins-Filho OA
Vaccine; 2009 Feb; 27(7):1008-17. PubMed ID: 19110023
[TBL] [Abstract][Full Text] [Related]
13. Isotype patterns of immunoglobulins: hallmarks for clinical status and tissue parasite density in Brazilian dogs naturally infected by Leishmania (Leishmania) chagasi.
Reis AB; Teixeira-Carvalho A; Vale AM; Marques MJ; Giunchetti RC; Mayrink W; Guerra LL; Andrade RA; Corrêa-Oliveira R; Martins-Filho OA
Vet Immunol Immunopathol; 2006 Aug; 112(3-4):102-16. PubMed ID: 16621021
[TBL] [Abstract][Full Text] [Related]
14. Decrease of the incidence of human and canine visceral leishmaniasis after dog vaccination with Leishmune in Brazilian endemic areas.
Palatnik-de-Sousa CB; Silva-Antunes I; Morgado Ade A; Menz I; Palatnik M; Lavor C
Vaccine; 2009 Jun; 27(27):3505-12. PubMed ID: 19464528
[TBL] [Abstract][Full Text] [Related]
15. Comparison of monoclonal and polyclonal antibodies for the detection of canine IgG1 and IgG2, and associations with infection outcome in Leishmania infantum naturally infected dogs.
Carson C; Quinnell RJ; Day MJ; Courtenay O
Vet Immunol Immunopathol; 2010 Feb; 133(2-4):264-8. PubMed ID: 19726090
[TBL] [Abstract][Full Text] [Related]
16. Failure of a multi-subunit recombinant leishmanial vaccine (MML) to protect dogs from Leishmania infantum infection and to prevent disease progression in infected animals.
Gradoni L; Foglia Manzillo V; Pagano A; Piantedosi D; De Luna R; Gramiccia M; Scalone A; Di Muccio T; Oliva G
Vaccine; 2005 Nov; 23(45):5245-51. PubMed ID: 16054272
[TBL] [Abstract][Full Text] [Related]
17. Antibody responses induced by Leish-Tec®, an A2-based vaccine for visceral leishmaniasis, in a heterogeneous canine population.
Testasicca MC; dos Santos MS; Machado LM; Serufo AV; Doro D; Avelar D; Tibúrcio AM; Abrantes Cde F; Machado-Coelho GL; Grimaldi G; Gazzinelli RT; Fernandes AP
Vet Parasitol; 2014 Aug; 204(3-4):169-76. PubMed ID: 24863572
[TBL] [Abstract][Full Text] [Related]
18. Relationship of Leishmania-specific IgG levels and IgG avidity with parasite density and clinical signs in canine leishmaniasis.
Teixeira Neto RG; Giunchetti RC; Carneiro CM; Vitor RW; Coura-Vital W; Quaresma PF; Ker HG; de Melo LA; Gontijo CM; Reis AB
Vet Parasitol; 2010 May; 169(3-4):248-57. PubMed ID: 20188477
[TBL] [Abstract][Full Text] [Related]
19. Protection against experimental visceral leishmaniasis infection in dogs immunized with purified excreted secreted antigens of Leishmania infantum promastigotes.
Lemesre JL; Holzmuller P; Cavaleyra M; Gonçalves RB; Hottin G; Papierok G
Vaccine; 2005 Apr; 23(22):2825-40. PubMed ID: 15780731
[TBL] [Abstract][Full Text] [Related]
20. IgG1/IgG2 antibody dichotomy in sera of vaccinated or naturally infected dogs with visceral leishmaniosis.
de Oliveira Mendes C; Paraguai de Souza E; Borja-Cabrera GP; Maria Melo Batista L; Aparecida dos Santos M; Ellner Parra L; Menz I; Palatnik M; Palatnik de Sousa CB
Vaccine; 2003 Jun; 21(19-20):2589-97. PubMed ID: 12744895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
